Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Finished Goods: 2010-2025

Historic Finished Goods for BIO-TECHNE (TECH) over the last 12 years, with Sep 2025 value amounting to $114.9 million.

  • BIO-TECHNE's Finished Goods rose 5.58% to $114.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $114.9 million, marking a year-over-year increase of 5.58%. This contributed to the annual value of $106.2 million for FY2025, which is 0.11% up from last year.
  • According to the latest figures from Q3 2025, BIO-TECHNE's Finished Goods is $114.9 million, which was up 8.18% from $106.2 million recorded in Q2 2025.
  • Over the past 5 years, BIO-TECHNE's Finished Goods peaked at $114.9 million during Q3 2025, and registered a low of $66.9 million during Q2 2022.
  • Its 3-year average for Finished Goods is $104.9 million, with a median of $106.2 million in 2025.
  • As far as peak fluctuations go, BIO-TECHNE's Finished Goods fell by 0.25% in 2022, and later surged by 38.14% in 2023.
  • BIO-TECHNE's Finished Goods (Quarterly) stood at $67.1 million in 2021, then decreased by 0.25% to $80.5 million in 2022, then rose by 27.76% to $102.9 million in 2023, then rose by 7.04% to $110.2 million in 2024, then rose by 5.58% to $114.9 million in 2025.
  • Its Finished Goods was $114.9 million in Q3 2025, compared to $106.2 million in Q2 2025 and $113.3 million in Q1 2025.